SARS CoV 2 Infection
Showing 1 - 25 of 61
SARS CoV 2 Infection Trial (RIPH2)
Not yet recruiting
- SARS CoV 2 Infection
- RIPH2
- (no location specified)
Nov 20, 2023
COVID-19, Vaccine-Preventable Diseases, SARS CoV 2 Infection Trial (Novavax COVID-19 vaccine (2023-2024 formula XBB containing),
Not yet recruiting
- COVID-19
- +4 more
- Novavax COVID-19 vaccine (2023-2024 formula XBB containing)
- Pfizer COVID-19 mRNA vaccine (2023-2024 formula XBB containing)
- (no location specified)
Sep 29, 2023
COVID-19, Infectious Disease, Symptomatic COVID-19 Infection Laboratory-Confirmed Trial in United States (RQ-001, Placebo)
Recruiting
- COVID-19
- +3 more
- RQ-001
- Placebo
-
Cullman, Alabama
- +8 more
Sep 28, 2023
SARS CoV 2 Infection, Influenza, Human Trial in Spain (BIMERVAX, SIIV)
Not yet recruiting
- SARS CoV 2 Infection
- Influenza, Human
- BIMERVAX
- SIIV
-
Santiago De Compostela, A Coruña, Spain
- +7 more
Aug 8, 2023
COVID-19 Transmission and Morbidity in Malawi
Recruiting
- SARS CoV 2 Infection
- SARS CoV 2 Vaccination
-
Boston, Massachusetts
- +1 more
Aug 6, 2023
Respiratory Viral Infection, SARS CoV 2 Infection Trial in Banjul
Active, not recruiting
- Respiratory Viral Infection
- SARS CoV 2 Infection
-
Banjul, Western Region, GambiaField study in the West Coast Region and Kanifing Municipality C
Jul 11, 2023
Influenza A, Influenza Type B, SARS CoV 2 Infection Trial in Raleigh (Diagnostic Test for identification of influenzas A,
Not yet recruiting
- Influenza A
- +3 more
- Diagnostic Test for identification of influenzas A, influenzas B, RSV and SARS-CoV-2 infections
-
Raleigh, North CarolinaWake Med
Jun 26, 2023
SARS CoV 2 Infection Trial in Monastir (Spray with Hypochlorous Acid Group, Spray with Placebo Group)
Recruiting
- SARS CoV 2 Infection
- Spray with Hypochlorous Acid Group
- Spray with Placebo Group
-
Monastir, TunisiaSemir Nouira
May 16, 2023
Long-term Sequelae of Coronavirus Disease 2019 Pneumonia With
Active, not recruiting
- COVID-19 Pneumonia
- +4 more
-
Faro, Portugal
- +1 more
Apr 26, 2023
COVID-19, Long COVID, Long Covid19 Trial in Paiporta, Valencia (Transcranial Direct Current Therapy (tDCS))
Not yet recruiting
- COVID-19
- +12 more
- Transcranial Direct Current Therapy (tDCS)
-
Paiporta, Valencia, Spain
- +1 more
Mar 21, 2023
ME/CFS, SARS CoV 2 Infection, Fatigue Syndrome, Chronic Trial in München
Recruiting
- ME/CFS
- +3 more
-
München, GermanyMünchen Klinik Schwabing
Mar 20, 2023
Cognitive Decline, COVID-19, SARS CoV 2 Infection Trial in Hangzhou (hyperbaric oxygen therapy, conventional oxygen therapy)
Not yet recruiting
- Cognitive Decline
- +2 more
- hyperbaric oxygen therapy
- conventional oxygen therapy
-
Hangzhou, Zhejiang, ChinaFirst Affiliated Hospital of Zhejiang Chinese Medical University
Feb 6, 2023
NIH RECOVER Tissue Pathology: Understanding Long-Term Impact of
Recruiting
- COVID-19
- SARS CoV 2 Infection
-
New York, New YorkNYU Langone Health
Jan 25, 2023
SARS CoV 2 Infection, COVID-19 Trial in Brussels (Humoral immunity)
Enrolling by invitation
- SARS CoV 2 Infection
- COVID-19
- Humoral immunity
-
Brussels, BelgiumSciensano
Jan 16, 2023
Cystic Fibrosis, Sickle Cell Disease, SARS CoV 2 Infection Trial in Irvine (Exercise)
Recruiting
- Cystic Fibrosis
- +2 more
- Exercise
-
Irvine, CaliforniaUniversity of California, Irvine
Jan 5, 2023
The Corona Study of Middle Norway
Completed
- SARS-CoV-2 Acute Respiratory Disease
- +2 more
- No intervention
-
Trondheim, MN, Norway
- +4 more
Dec 1, 2022
COVID-19, Neuro-Degenerative Disease, Psychological Trial in Vigo, Ourense (Sessions of cognitive stimulation)
Not yet recruiting
- COVID-19
- +3 more
- Sessions of cognitive stimulation
-
Vigo, Pontevedra, Spain
- +1 more
Nov 29, 2022
COVID-19, Fatigue, Distress Respiratory Syndrome Trial in Ourense, Vigo (Experimental tests)
Not yet recruiting
- COVID-19
- +5 more
- Experimental tests
-
Ourense, Spain
- +6 more
Nov 28, 2022
SARS CoV 2 Infection, COVID-19 Trial in Los Angeles (Bemnifosbuvir (BEM), Placebo)
Recruiting
- SARS CoV 2 Infection
- COVID-19
- Bemnifosbuvir (BEM)
- Placebo
-
Los Angeles, CaliforniaAtea Study Site
Nov 26, 2022
COVID-19, SARS CoV 2 Infection Trial in Australia (NVX-CoV2515, NVX-Cov2373, NVX-CoV2373 + NVX-CoV2515)
Active, not recruiting
- COVID-19
- SARS CoV 2 Infection
- NVX-CoV2515
- +2 more
-
Bruce, Australian Capital Territory, Australia
- +18 more
Nov 23, 2022
SARS CoV 2 Infection, Alveolar; Injury, Children Trial in Istanbul
Completed
- SARS CoV 2 Infection
- +3 more
-
Istanbul, TurkeyHaseki Training and Research Hospital
Nov 17, 2022
COVID-19, SARS CoV 2 Infection Trial in Minneapolis (LumiraDX, RightSign, Case Control)
Completed
- COVID-19
- SARS CoV 2 Infection
- LumiraDX
- +2 more
-
Minneapolis, MinnesotaUniversity of Minnesota
Nov 18, 2022
SARS CoV 2 Infection Trial in Newark (Testing for SARS CoV2 Antigen)
Completed
- SARS CoV 2 Infection
- Testing for SARS CoV2 Antigen
-
Newark, New JerseyRutgers School of Dental Medicine
Nov 4, 2022